Skip to main content
NCBI home page
Thorax logoLink to Thorax
editorial
. 1993 Aug;48(8):779–780. doi: 10.1136/thx.48.8.779

Management of malignant pleural effusion.

P T Reid, R M Rudd
PMCID: PMC464699  PMID: 7692616

Full text

PDF
779

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aelony Y. Thoracoscopic talc poudrage. Comparison with tetracycline and use in Hodgkin's disease. Chest. 1992 Dec;102(6):1922–1924. doi: 10.1378/chest.102.6.1922. [DOI] [PubMed] [Google Scholar]
  2. Anderson C. B., Philpott G. W., Ferguson T. B. The treatment of malignant pleural effusions. Cancer. 1974 Apr;33(4):916–922. doi: 10.1002/1097-0142(197404)33:4<916::aid-cncr2820330405>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  3. Anderson C. B., Philpott G. W., Ferguson T. B. The treatment of malignant pleural effusions. Cancer. 1974 Apr;33(4):916–922. doi: 10.1002/1097-0142(197404)33:4<916::aid-cncr2820330405>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  4. Bayly T. C., Kisner D. L., Sybert A., Macdonald J. S., Tsou E., Schein P. S. Tetracycline and quinacrine in the control of malignant pleural effusions. A randomized trial. Cancer. 1978 Mar;41(3):1188–1192. doi: 10.1002/1097-0142(197803)41:3<1188::aid-cncr2820410357>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  5. Bayly T. C., Kisner D. L., Sybert A., Macdonald J. S., Tsou E., Schein P. S. Tetracycline and quinacrine in the control of malignant pleural effusions. A randomized trial. Cancer. 1978 Mar;41(3):1188–1192. doi: 10.1002/1097-0142(197803)41:3<1188::aid-cncr2820410357>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  6. Bouchama A., Chastre J., Gaudichet A., Soler P., Gibert C. Acute pneumonitis with bilateral pleural effusion after talc pleurodesis. Chest. 1984 Nov;86(5):795–797. doi: 10.1378/chest.86.5.795. [DOI] [PubMed] [Google Scholar]
  7. Friedman M. A., Slater E. Malignant pleural effusions. Cancer Treat Rev. 1978 Jun;5(2):49–66. doi: 10.1016/s0305-7372(78)80006-1. [DOI] [PubMed] [Google Scholar]
  8. Friedman M. A., Slater E. Malignant pleural effusions. Cancer Treat Rev. 1978 Jun;5(2):49–66. doi: 10.1016/s0305-7372(78)80006-1. [DOI] [PubMed] [Google Scholar]
  9. Heffner J. E., Unruh L. C. Tetracycline pleurodesis. Adios, farewell, adieu. Chest. 1992 Jan;101(1):5–7. doi: 10.1378/chest.101.1.5. [DOI] [PubMed] [Google Scholar]
  10. Li D. J., Wang Y. R., Tan X. Y., Wang H. Z., Yao X. D., Ba D. N. A new approach to the treatment of malignant effusion. Chin Med J (Engl) 1990 Dec;103(12):998–1002. [PubMed] [Google Scholar]
  11. Martini N., Bains M. S., Beattie E. J., Jr Indications for pleurectomy in malignant effusion. Cancer. 1975 Mar;35(3):734–738. doi: 10.1002/1097-0142(197503)35:3<734::aid-cncr2820350328>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  12. Martini N., Bains M. S., Beattie E. J., Jr Indications for pleurectomy in malignant effusion. Cancer. 1975 Mar;35(3):734–738. doi: 10.1002/1097-0142(197503)35:3<734::aid-cncr2820350328>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  13. McAlpine L. G., Hulks G., Thomson N. C. Management of recurrent malignant pleural effusion in the United Kingdom: survey of clinical practice. Thorax. 1990 Sep;45(9):699–701. doi: 10.1136/thx.45.9.699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. McLeod D. T., Calverley P. M., Millar J. W., Horne N. W. Further experience of Corynebacterium parvum in malignant pleural effusion. Thorax. 1985 Jul;40(7):515–518. doi: 10.1136/thx.40.7.515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Milsom J. W., Kron I. L., Rheuban K. S., Rodgers B. M. Chylothorax: an assessment of current surgical management. J Thorac Cardiovasc Surg. 1985 Feb;89(2):221–227. [PubMed] [Google Scholar]
  16. Ohri S. K., Oswal S. K., Townsend E. R., Fountain S. W. Early and late outcome after diagnostic thoracoscopy and talc pleurodesis. Ann Thorac Surg. 1992 Jun;53(6):1038–1041. doi: 10.1016/0003-4975(92)90384-g. [DOI] [PubMed] [Google Scholar]
  17. Rinaldo J. E., Owens G. R., Rogers R. M. Adult respiratory distress syndrome following intrapleural instillation of talc. J Thorac Cardiovasc Surg. 1983 Apr;85(4):523–526. [PubMed] [Google Scholar]
  18. Ruckdeschel J. C. Management of malignant pleural effusion: an overview. Semin Oncol. 1988 Jun;15(3 Suppl 3):24–28. [PubMed] [Google Scholar]
  19. Ruckdeschel J. C., Moores D., Lee J. Y., Einhorn L. H., Mandelbaum I., Koeller J., Weiss G. R., Losada M., Keller J. H. Intrapleural therapy for malignant pleural effusions. A randomized comparison of bleomycin and tetracycline. Chest. 1991 Dec;100(6):1528–1535. doi: 10.1378/chest.100.6.1528. [DOI] [PubMed] [Google Scholar]
  20. Sahn S. A., Good J. T., Jr The effect of common sclerosing agents on the rabbit pleural space. Am Rev Respir Dis. 1981 Jul;124(1):65–67. doi: 10.1164/arrd.1981.124.1.65. [DOI] [PubMed] [Google Scholar]
  21. Webb W. R., Ozmen V., Moulder P. V., Shabahang B., Breaux J. Iodized talc pleurodesis for the treatment of pleural effusions. J Thorac Cardiovasc Surg. 1992 May;103(5):881–886. [PubMed] [Google Scholar]
  22. Yasumoto K., Ogura T. Intrapleural application of recombinant interleukin-2 in patients with malignant pleurisy due to lung cancer. A multi-institutional cooperative study. Biotherapy. 1991;3(4):345–349. doi: 10.1007/BF02221327. [DOI] [PubMed] [Google Scholar]
  23. Zaloznik A. J., Oswald S. G., Langin M. Intrapleural tetracycline in malignant pleural effusions. A randomized study. Cancer. 1983 Feb 15;51(4):752–755. doi: 10.1002/1097-0142(19830215)51:4<752::aid-cncr2820510434>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES